price
LI
NASDAQ · LIFE
aTyr Pharma, Inc.
Healthcare · Biotechnology
$39.85
Up+$2.14 (+5.67%)
Updated Sep 8, 2026, 3:22 AM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 131.12M
- P/E ratio
- -0.99
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 1.04M
- Avg. volume
- 496.17K
Price performance
LIFE price history
1M range · 20 trading sessions · Daily adjusted prices
LIFE closed at $39.85 after 20 trading sessions, up 22.88% for the selected period.
- Last close
- $39.85
- Period change
- +22.88%
- Period low
- $32.43
- Period high
- $39.85
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 4, 2026 | $37.76 | $39.89 | $36.5801 | $39.85 | 1.04M |
| Sep 3, 2026 | $37.48 | $38.85 | $37.415 | $37.71 | 722.14K |
| Sep 2, 2026 | $35.66 | $37.28 | $34.85 | $36.80 | 1.22M |
| Sep 1, 2026 | $35.06 | $36.01 | $34.83 | $35.00 | 1.07M |
| Aug 31, 2026 | $38.64 | $38.64 | $35.77 | $36.33 | 1.13M |
| Aug 28, 2026 | $39.60 | $40.19 | $37.73 | $38.64 | 1.09M |
| Aug 27, 2026 | $39.40 | $40.93 | $38.72 | $39.44 | 987.12K |
| Aug 26, 2026 | $38.24 | $40.9699 | $38.00 | $39.11 | 1.61M |
| Aug 25, 2026 | $36.96 | $38.94 | $36.62 | $38.56 | 2.02M |
| Aug 24, 2026 | $33.05 | $37.17 | $32.00 | $36.72 | 2.62M |
| Aug 21, 2026 | $33.90 | $34.49 | $32.51 | $34.16 | 850.09K |
| Aug 20, 2026 | $32.86 | $34.225 | $31.845 | $33.52 | 1.53M |
| Aug 19, 2026 | $34.37 | $34.37 | $32.2325 | $32.85 | 1.04M |
| Aug 18, 2026 | $34.06 | $35.61 | $32.60 | $34.01 | 1.51M |
| Aug 17, 2026 | $34.03 | $35.4725 | $33.30 | $35.17 | 1.65M |
| Aug 14, 2026 | $35.04 | $35.69 | $33.88 | $34.02 | 1.24M |
| Aug 13, 2026 | $33.84 | $35.30 | $33.12 | $34.80 | 1.47M |
| Aug 12, 2026 | $33.50 | $34.24 | $31.71 | $33.59 | 1.56M |
| Aug 11, 2026 | $32.43 | $33.80 | $31.21 | $33.45 | 989.07K |
| Aug 10, 2026 | $31.05 | $32.86 | $31.05 | $32.43 | 1.19M |
Latest LIFE news
The latest Smart Investors Daily articles mentioning LIFE.
Stock researchResearch & News · Analysis
Loading stock research…